I TO I Trademark

Trademark Overview

On Tuesday, November 1, 2022, a trademark application was filed for I TO I with the United States Patent and Trademark Office. The USPTO has given the I TO I trademark a serial number of 97980305. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, June 27, 2025. This trademark is owned by Nona Biosciences US, Inc.. The I TO I trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technical research in the field of pharmaceutical studies; Research and development of new products for others; Scientific investigations for medical purposes; Development of pharmaceutical preparations and medicines; Medical laboratory services; Scientific research in the nature of conducting clinical trials for others; Medical research; Biological research; Biochemical research and analysis; Testing of pharmaceuticals
i to i

General Information

Serial Number97980305
Word MarkI TO I
Filing DateTuesday, November 1, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, June 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2024

Trademark Statements

Goods and ServicesTechnical research in the field of pharmaceutical studies; Research and development of new products for others; Scientific investigations for medical purposes; Development of pharmaceutical preparations and medicines; Medical laboratory services; Scientific research in the nature of conducting clinical trials for others; Medical research; Biological research; Biochemical research and analysis; Testing of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 17, 2022
Primary Code042
First Use Anywhere DateMonday, November 14, 2022
First Use In Commerce DateMonday, November 21, 2022

Trademark Owner History

Party NameNona Biosciences US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNatick, MA 01760
Party NameNona Biosciences US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events

Event DateEvent Description
Friday, November 4, 2022NEW APPLICATION ENTERED
Thursday, November 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 16, 2023ASSIGNED TO EXAMINER
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Monday, June 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 26, 2023NON-FINAL ACTION E-MAILED
Monday, July 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 23, 2024SOU EXTENSION 1 FILED
Tuesday, September 24, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, September 24, 2024SOU EXTENSION 1 GRANTED
Tuesday, December 26, 2023ASSIGNED TO LIE
Tuesday, December 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 24, 2024USE AMENDMENT FILED
Tuesday, September 24, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 24, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, September 24, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, December 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 26, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 27, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, June 27, 2025DIVISIONAL PROCESSING COMPLETE
Saturday, June 28, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

research medical scientific development others pharmaceutical trials clinical conducting biological